CoChat

Solubility-Aware Protein Binding Peptide Design Using AlphaFold

Open access
Kosugi, Takatsugu, Ohue, Masahito · 2022 · Biomedicines
Cited by 31

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

New protein–protein interactions (PPIs) are identified, but PPIs have different physicochemical properties compared with conventional targets, making it difficult to use small molecules. Peptides offer a new modality to target PPIs, but designing appropriate peptide sequences by computation is challenging. Recently, AlphaFold and RoseTTAFold have made it possible to predict protein structures from amino acid sequences with ultra-high accuracy, enabling de novo protein design. We designed peptides likely to have PPI as the target protein using the “binder hallucination” protocol of AfDesign, a de novo protein design method using AlphaFold. However, the solubility of the peptides tended to be low. Therefore, we designed a solubility loss function using solubility indices for amino acids and developed a solubility-aware AfDesign binder hallucination protocol. The peptide solubility in sequences designed using the new protocol increased with the weight of the solubility loss function; moreover, they captured the characteristics of the solubility indices. Moreover, the new protocol sequences tended to have higher affinity than random or single residue substitution sequences when evaluated by docking binding affinity. Our approach shows that it is possible to design peptide sequences that can bind to the interface of PPI while controlling solubility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines10071626

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 34

  1. Bonetta, 2010, Interactome under Construction, Nature, 468, 851, 10.1038/468851a · DOI · Paper page
  2. Toogood, 2002, Inhibition of Protein-Protein Association by Small Molecules: Approaches and Progress, J. Med. Chem., 45, 1543, 10.1021/jm010468s · DOI · Paper page
  3. Dev, 2004, Making protein interactions druggable: Targeting PDZ domains, Nat. Rev. Drug Discov., 3, 1047, 10.1038/nrd1578 · DOI · Paper page
  4. Souers, 2013, ABT-199, a Potent and Selective BCL-2 Inhibitor, Achieves Antitumor Activity While Sparing Platelets, Nat. Med., 19, 202, 10.1038/nm.3048 · DOI · Paper page
  5. Shin, 2020, Current challenges and opportunities in designing protein–protein interaction targeted drugs, Adv. Appl. Bioinform. Chem., 13, 11
  6. Truong, 2021, Analysis of Physicochemical Properties of Protein–Protein Interaction Modulators Suggests Stronger Alignment with the “Rule of Five”, RSC Med. Chem., 12, 1731, 10.1039/D1MD00213A · DOI
  7. Kosugi, T., and Ohue, M. (2021). Quantitative Estimate Index for Early-Stage Screening of Compounds Targeting Protein-Protein Interactions. Int. J. Mol. Sci., 22. · DOI
  8. Wodak, 2002, Structural Basis of Macromolecular Recognition, Adv. Protein Chem., 61, 9, 10.1016/S0065-3233(02)61001-0 · DOI · Paper page
  9. Conte, 1999, The Atomic Structure of Protein-Protein Recognition Sites11Edited by A. R. Fersht, J. Mol. Biol., 285, 2177, 10.1006/jmbi.1998.2439 · DOI · Paper page
  10. Smith, 2012, Features of Protein–Protein Interactions That Translate into Potent Inhibitors: Topology, Surface Area and Affinity, Expert Rev. Mol. Med., 14, e16, 10.1017/erm.2012.10 · DOI · Paper page
  11. Wells, 2007, Reaching for High-Hanging Fruit in Drug Discovery at Protein–Protein Interfaces, Nature, 450, 1001, 10.1038/nature06526 · DOI · Paper page
  12. Cabri, 2021, Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives, Front. Mol. Biosci., 8, 565, 10.3389/fmolb.2021.697586 · DOI · Paper page
  13. Wu, 2016, Advancement and Applications of Peptide Phage Display Technology in Biomedical Science, J. Biomed. Sci., 23, 8, 10.1186/s12929-016-0223-x · DOI · Paper page
  14. Nemoto, 1997, In Vitro Virus: Bonding of MRNA Bearing Puromycin at the 3′-Terminal End to the C-Terminal End of Its Encoded Protein on the Ribosome in Vitro, FEBS Lett., 414, 405, 10.1016/S0014-5793(97)01026-0 · DOI · Paper page
  15. Roberts, 1997, RNA-Peptide Fusions for the in Vitro Selection of Peptides And Proteins, Proc. Natl. Acad. Sci. USA, 94, 12297, 10.1073/pnas.94.23.12297 · DOI · Paper page
  16. Das, 2021, Accelerated Antimicrobial Discovery via Deep Generative Models and Molecular Dynamics Simulations, Nat. Biomed. Eng., 5, 613, 10.1038/s41551-021-00689-x · DOI · Paper page
  17. Cardoso, 2020, Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates?, Front. Microbiol., 10, 3097, 10.3389/fmicb.2019.03097 · DOI · Paper page
  18. Capecchi, 2020, Populating Chemical Space with Peptides Using a Genetic Algorithm, J. Chem. Inf. Model., 60, 121, 10.1021/acs.jcim.9b01014 · DOI
  19. Baran, 2017, Principles for Computational Design of Binding Antibodies, Proc. Natl. Acad. Sci. USA, 114, 10900, 10.1073/pnas.1707171114 · DOI · Paper page
  20. Gulsevin, A., and Meiler, J. (2022). Benchmarking Peptide Structure Prediction with AlphaFold2. bioRxiv. · DOI
  21. Fosgerau, 2015, Peptide Therapeutics: Current Status and Future Directions, Drug Discov., 20, 122
  22. Esposito, 2006, Enhancement of Soluble Protein Expression through the Use of Fusion Tags, Curr. Opin. Biotechnol., 17, 353, 10.1016/j.copbio.2006.06.003 · DOI · Paper page
  23. Wu, 2010, Structure-Based Engineering of a Monoclonal Antibody for Improved Solubility, Protein Eng. Des. Sel., 23, 643, 10.1093/protein/gzq037 · DOI · Paper page
  24. Mant, 2009, Intrinsic Amino Acid Side-Chain Hydrophilicity/Hydrophobicity Coefficients Determined by Reversed-Phase High-Performance Liquid Chromatography of Model Peptides: Comparison with Other Hydrophilicity/Hydrophobicity Scales, Pept. Sci., 92, 573, 10.1002/bip.21316 · DOI
  25. Argos, 1982, Structural Prediction of Membrane-Bound Proteins, Eur. J. Biochem., 128, 565, 10.1111/j.1432-1033.1982.tb07002.x · DOI · Paper page
  26. Kyte, 1982, A Simple Method for Displaying the Hydropathic Character of a Protein, J. Mol. Biol., 157, 105, 10.1016/0022-2836(82)90515-0 · DOI · Paper page
  27. Zhang, 2019, AutoDock CrankPep: Combining Folding and Docking to Predict Protein–Peptide Complexes, Bioinformatics, 35, 5121, 10.1093/bioinformatics/btz459 · DOI · Paper page
  28. Word, 1999, Asparagine and Glutamine: Using Hydrogen Atom Contacts in the Choice of Side-Chain Amide Orientation, J. Mol. Biol., 285, 1735, 10.1006/jmbi.1998.2401 · DOI · Paper page
  29. Morris, 2009, AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility, J. Comput. Chem., 30, 2785, 10.1002/jcc.21256 · DOI · Paper page
  30. Crooks, 2004, WebLogo: A Sequence Logo Generator, Genome Res., 14, 1188, 10.1101/gr.849004 · DOI · Paper page
  31. Chang, L., and Perez, A. (2022). AlphaFold Encodes the Principles to Identify High Affinity Peptide Binders. bioRxiv. · DOI
  32. Adasme, 2021, PLIP 2021: Expanding the Scope of the Protein-Ligand Interaction Profiler to DNA and RNA, Nucleic Acids Res., 49, W530, 10.1093/nar/gkab294 · DOI · Paper page
  33. Weng, 2020, Comprehensive Evaluation of Fourteen Docking Programs on Protein–Peptide Complexes, J. Chem. Theory Comput., 16, 3959, 10.1021/acs.jctc.9b01208 · DOI · Paper page
  34. Shin, 2017, In Silico Structure-Based Approaches to Discover Protein-Protein Interaction-Targeting Drugs, Methods, 131, 22, 10.1016/j.ymeth.2017.08.006 · DOI · Paper page

Cited by

See all 31

Metadata

Authors
Kosugi, T., & Ohue, M.
Venue
Biomedicines
Publisher
MDPI AG
Published
2022-07-07
Volume
10
Issue
7
Pages
1626
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4284710673
Cited by
31
References
19
FWCI
1.66
Type
journal article
Language
en
Open access
gold
Funders
  • Japan Science and Technology Agency (JST) FOREST (JPMJFR216J, JPMJAX20A3, 20H04280, JP22ama121026)
  • JST ACT-X (JPMJFR216J, JPMJAX20A3, 20H04280, JP22ama121026)
  • Japan Society for the Promotion of Science (JSPS) KAKENHI (JPMJFR216J, JPMJAX20A3, 20H04280, JP22ama121026)
  • Japan Agency for Medical Research and Development (AMED) Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) (JPMJFR216J, JPMJAX20A3, 20H04280, JP22ama121026)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Solubility-Aware Protein Binding Peptide Design Using AlphaFold. https://app.cochat.ai/papers/10.3390/biomedicines10071626
The paper
Kosugi, T., & Ohue, M. (2022). Solubility-Aware Protein Binding Peptide Design Using AlphaFold. Biomedicines. https://doi.org/10.3390/biomedicines10071626

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.